Onconova Therapeutics (ONTX) Regains Compliance with Nasdaq Continued Listing Requirement

Go back to Onconova Therapeutics (ONTX) Regains Compliance with Nasdaq Continued Listing Requirement

Onconova Therapeutics Regains Compliance with Nasdaq Continued Listing Requirement

February 24, 2021 8:00 AM EST

NEWTOWN, Pa., Feb. 24, 2021 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX) (Onconova), a biopharmaceutical company focused on discovering and developing novel products for patients with cancer, announces receipt of notification from Nasdaq that the Company has regained compliance with the minimum bid price requirement of Nasdaq Listing Rule 5550(a)(2) because the Companys common stock had a closing price of at least $1.00 per share for a minimum 10 consecutive business days. As previously reported, the Company was granted until April 5, 2021 to meet this requirement.

Steven Fruchtman, M.D.,... More